{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T22:16:31Z","timestamp":1773872191030,"version":"3.50.1"},"reference-count":100,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"crossref","award":["200508GMH"],"award-info":[{"award-number":["200508GMH"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"crossref","award":["MOP-15007"],"award-info":[{"award-number":["MOP-15007"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009670","name":"NARSAD","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009670","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Eli Lilly"},{"DOI":"10.13039\/100001455","name":"American Foundation for Suicide Prevention","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001455","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.pnpbp.2011.11.018","type":"journal-article","created":{"date-parts":[[2011,12,9]],"date-time":"2011-12-09T04:29:12Z","timestamp":1323404952000},"page":"62-75","source":"Crossref","is-referenced-by-count":32,"title":["Dopamine D4 and D5 receptor gene variant effects on clozapine response in schizophrenia: Replication and exploration"],"prefix":"10.1016","volume":"37","author":[{"given":"Rudi","family":"Hwang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun K.","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clement C.","family":"Zai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Felsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eli","family":"Remington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tessa","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan P.","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renan P.","family":"Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven G.","family":"Potkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey A.","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert Y.","family":"Meltzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James L.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2011.11.018_bb0005","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ajmg.1320600306","article-title":"DRD4 dopamine receptor genotype and CSF monoamine metabolites in Finnish alcoholics and controls","volume":"60","author":"Adamson","year":"1995","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0010","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.275.5306.1586","article-title":"Linking mind and brain in the study of mental illnesses: a project for a scientific psychopathology","volume":"275","author":"Andreasen","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0015","series-title":"Diagnostic and statistical manual of mental disorders (DSM-IV)","author":"APA","year":"1994"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0020","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1046\/j.1471-4159.1995.65031157.x","article-title":"Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants","volume":"65","author":"Asghari","year":"1995","journal-title":"J Neurochem"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0025","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0026-895X(25)09692-0","article-title":"Dopamine D4 receptor repeat: analysis of different native and mutant forms of the human and rat genes","volume":"46","author":"Asghari","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0030","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1093\/hmg\/11.20.2517","article-title":"Pharmacogenomics in schizophrenia: the quest for individualized therapy","volume":"11","author":"Basile","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0035","doi-asserted-by":"crossref","first-page":"7821","DOI":"10.1523\/JNEUROSCI.15-12-07821.1995","article-title":"Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain","volume":"15","author":"Bergson","year":"1995","journal-title":"J Neurosci"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0505","author":"Buchner"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0045","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ajmg.b.30557","article-title":"Analysis of DRD4 and DAT polymorphisms and behavioral inhibition in healthy adults: implications for impulsivity","volume":"147B","author":"Congdon","year":"2008","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0050","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.biopsych.2004.08.008","article-title":"Functional effects of a tandem duplication polymorphism in the 5\u2032flanking region of the DRD4 gene","volume":"56","author":"D'Souza","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0055","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/archpsyc.1990.01810140090014","article-title":"Effects of the D-1 agonist SKF-38393 combined with haloperidol in schizophrenic patients","volume":"47","author":"Davidson","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0079-6123(08)00905-9","article-title":"Distribution of 5-HT and DA receptors in primate prefrontal cortex: implications for pathophysiology and treatment","volume":"172","author":"de Almeida","year":"2008","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0065","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/BF02246069","article-title":"Differential effects of the D1-DA receptor antagonist SCH39166 on positive and negative symptoms of schizophrenia","volume":"121","author":"Den Boer","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"issue":"66","key":"10.1016\/j.pnpbp.2011.11.018_bb0070","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000119108","article-title":"Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data","volume":"2008","author":"Dudbridge","year":"2008","journal-title":"Hum Hered"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0075","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/1471-2105-7-227","article-title":"MIDAS: software for analysis and visualisation of interallelic disequilibrium between multiallelic markers","volume":"7","author":"Gaunt","year":"2006","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0080","series-title":"Schizophrenia","article-title":"Neurocognitive deficits in schizophrenia","author":"Goldberg","year":"1995"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0085","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10517-008-0007-8","article-title":"Association of dopamine receptor D5 gene polymorphism with peculiarities of voluntary attention in schizophrenic patients and their relatives","volume":"145","author":"Golimbet","year":"2008","journal-title":"Bull Exp Biol Med"},{"issue":"Pt 6","key":"10.1016\/j.pnpbp.2011.11.018_bb0090","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/brain\/109.6.1127","article-title":"The effects of lateralized frontal lesions on mood regulation","volume":"109","author":"Grafman","year":"1986","journal-title":"Brain"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0095","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1089\/cap.2004.14.564","article-title":"Dopamine receptor 4 (DRD4) 7-repeat allele predicts methylphenidate dose response in children with attention deficit hyperactivity disorder: a pharmacogenetic study","volume":"14","author":"Hamarman","year":"2004","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0100","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/genetics\/117.2.331","article-title":"Gametic disequilibrium measures: proceed with caution","volume":"117","author":"Hedrick","year":"1987","journal-title":"Genetics"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0105","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1111\/j.1460-9568.2007.05921.x","article-title":"D4 receptor gene variation modulates activation of prefrontal cortex during working memory","volume":"26","author":"Herrmann","year":"2007","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0110","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0169-328X(00)00015-2","article-title":"Dopamine D-5 receptor modulates hippocampal acetylcholine release","volume":"76","author":"Hersi","year":"2000","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0115","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1055\/s-0030-1248315","article-title":"Familial differential treatment response in schizophrenia\u2014lessons from a case of three affected siblings","volume":"43","author":"Hoyer","year":"2010","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0120","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1037\/0033-2909.130.1.66","article-title":"Population stratification in the candidate gene study: fatal threat or red herring?","volume":"30","author":"Hutchison","year":"2004","journal-title":"Psychol Bull"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0125","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00213-005-2223-5","article-title":"Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory\/intolerant populations","volume":"181","author":"Hwang","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0130","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1177\/0269881106072341","article-title":"Association study of four dopamine D1 receptor gene polymorphisms and clozapine treatment response","volume":"21","author":"Hwang","year":"2007","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0135","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.euroneuro.2005.09.004","article-title":"Dopamine D2 receptor gene variants and quantitative measures of positive and negative symptom response following clozapine treatment","volume":"16","author":"Hwang","year":"2006","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0140","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/tpj.2009.65","article-title":"Effect of dopamine D3 receptor gene polymorphisms and clozapine treatment response: exploratory analysis of nine polymorphisms and meta-analysis of the Ser9Gly variant","volume":"10","author":"Hwang","year":"2010","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0145","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0006-3223(98)00134-6","article-title":"Dopamine D4 receptor gene polymorphisms and neuroleptic response in schizophrenia","volume":"44","author":"Hwu","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0150","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nature02168","article-title":"The international HapMap project","volume":"426","author":"IHMC","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0155","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.2217\/14622416.9.10.1437","article-title":"Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in first-episode schizophrenia","volume":"9","author":"Ikeda","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0160","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/FPC.0b013e3283050107","article-title":"Polymorphisms affecting gene transcription and mRNA processing in pharmacogenetic candidate genes: detection through allelic expression imbalance in human target tissues","volume":"18","author":"Johnson","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0165","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00008571-199910000-00003","article-title":"Comparative pharmacological and functional analysis of the human dopamine D4.2 and D4.10 receptor variants","volume":"9","author":"Jovanovic","year":"1999","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0170","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/sj.mp.4000729","article-title":"Dopamine D4 receptor 48-bp repeat polymorphism: no association with response to antipsychotic treatment, but association with catatonic schizophrenia","volume":"5","author":"Kaiser","year":"2000","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0175","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0180","first-page":"322","article-title":"The current status of neuroleptic therapy","volume":"50","author":"Kane","year":"1989","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0185","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.pnpbp.2003.09.004","article-title":"Half a century of antipsychotics and still a central role for dopamine D2 receptors","volume":"27","author":"Kapur","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0190","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/BF02246071","article-title":"NNC 01\u20130687, a selective dopamine D1 receptor antagonist, in the treatment of schizophrenia","volume":"121","author":"Karle","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0195","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1021\/bi992354c","article-title":"Selective reconstitution of human D4 dopamine receptor variants with Gi alpha subtypes","volume":"39","author":"Kazmi","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0200","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/ajmg.b.30444","article-title":"Association between the 120-bp duplication of the dopamine D4 receptor gene and attention deficit hyperactivity disorder: genetic and molecular analyses","volume":"144B","author":"Kereszturi","year":"2007","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0205","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0924-977X(96)00380-X","article-title":"Dopamine D4 receptor gene polymorphisms: relation to ethnicity, no association with schizophrenia and response to clozapine in Israeli subjects","volume":"7","author":"Kohn","year":"1997","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0210","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1093\/nar\/19.19.5444","article-title":"A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies","volume":"19","author":"Lahiri","year":"1991","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0215","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/genetics\/49.1.49","article-title":"The interaction of selection and linkage. I. General considerations; heterotic models","volume":"49","author":"Lewontin","year":"1964","journal-title":"Genetics"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0220","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1093\/hmg\/ddl152","article-title":"Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD)","volume":"15","author":"Li","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0225","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/hmg\/2.6.767","article-title":"A hypervariable segment in the human dopamine receptor D4 (DRD4) gene","volume":"2","author":"Lichter","year":"1993","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0230","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0022-3565(24)36627-3","article-title":"Down-regulation of the D1 and D5 dopamine receptors in the primate prefrontal cortex by chronic treatment with antipsychotic drugs. The Journal of pharmacology and experimental therapeutics","volume":"281","author":"Lidow","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0235","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1073\/pnas.91.10.4353","article-title":"A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex","volume":"91","author":"Lidow","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0240","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0245","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00041444-200212000-00003","article-title":"Dopamine system genes and attention deficit hyperactivity disorder: a meta-analysis","volume":"12","author":"Maher","year":"2002","journal-title":"Psychiatr Genet"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0250","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1192\/bjp.178.1.86","article-title":"Olanzapine: concordant response in monozygotic twins with schizophrenia","volume":"178","author":"Mata","year":"2001","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0255","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.pbb.2009.03.010","article-title":"The DRD4 exon 3 VNTR polymorphism and addiction-related phenotypes: a review","volume":"93","author":"McGeary","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0260","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1097\/01.chi.0000235083.40285.08","article-title":"Pharmacogenetics of methylphenidate response in preschoolers with ADHD","volume":"45","author":"McGough","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0265","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/schbul\/17.2.263","article-title":"The mechanism of action of novel antipsychotic drugs","volume":"17","author":"Meltzer","year":"1991","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0270","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/ajmg.b.30107","article-title":"Quantitative trait locus analysis of candidate gene alleles associated with attention deficit hyperactivity disorder (ADHD) in five genes: DRD4, DAT1, DRD5, SNAP-25, and 5HT1B","volume":"133B","author":"Mill","year":"2005","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0275","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/1096-8628(2001)9999:9999<::AID-AJMG1163>3.0.CO;2-2","article-title":"Markers close to the dopamine D5 receptor gene (DRD5) show significant association with schizophrenia but not bipolar disorder","volume":"105","author":"Muir","year":"2001","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0280","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1093\/emboj\/17.19.5734","article-title":"Identification of Bach2 as a B-cell-specific partner for small maf proteins that negatively regulate the immunoglobulin heavy chain gene 3\u2032 enhancer","volume":"17","author":"Muto","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0285","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1086\/383251","article-title":"A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other","volume":"74","author":"Nyholt","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0290","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/385634a0","article-title":"Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET","volume":"385","author":"Okubo","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0295","series-title":"Analysis of human genetic linkage. 3rd","author":"Ott","year":"1999"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0300","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1017\/S109285290001186X","article-title":"Variability in response to clozapine: potential role of cytochrome P450 1A2 and the dopamine D4 receptor gene","volume":"4","author":"Ozdemir","year":"1999","journal-title":"CNS Spectr"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0305","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1086\/344582","article-title":"Regarding \u201cTesting for population subdivision and association in four case\u2013control studies\u201d","volume":"71","author":"Pankow","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0310","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/BF00201581","article-title":"(G)n-mononucleotide polymorphism in the human D4 dopamine receptor (DRD4) gene","volume":"93","author":"Petronis","year":"1994","journal-title":"Hum Genet"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0315","doi-asserted-by":"crossref","first-page":"38313","DOI":"10.1074\/jbc.M401610200","article-title":"The tumor suppressor gene HIC1 (hypermethylated in cancer 1) is a sequence-specific transcriptional repressor: definition of its consensus binding sequence and analysis of its DNA binding and repressive properties","volume":"279","author":"Pinte","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0320","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/sj.mp.4001191","article-title":"D1 receptor alleles predict PET metabolic correlates of clinical response to clozapine","volume":"8","author":"Potkin","year":"2003","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0325","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1001\/archpsyc.1994.03950110072009","article-title":"Allelic variation in the D4 dopamine receptor (DRD4) gene does not predict response to clozapine","volume":"51","author":"Rao","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0330","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/ajmg.b.30473","article-title":"Novelty seeking and the dopamine D4 receptor gene (DRD4) revisited in Asians: haplotype characterization and relevance of the 2-repeat allele","volume":"144B","author":"Reist","year":"2007","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0335","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0065-2660(07)00412-9","article-title":"Methods for handling multiple testing","volume":"60","author":"Rice","year":"2008","journal-title":"Adv Genet"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0340","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0893-133X(96)00090-5","article-title":"Efficacy and side-effects of clozapine: testing for association with allelic variation in the dopamine D4 receptor gene","volume":"15","author":"Rietschel","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0345","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.2174\/0929867043455503","article-title":"Capillary electrophoresis study on DNA-protein complex formation in the polymorphic 5\u2032 upstream region of the dopamine D4 receptor (DRD4) gene","volume":"11","author":"Ronai","year":"2004","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0350","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.schres.2004.10.002","article-title":"The dopamine D4 receptor VNTR in Polish schizophrenia patients","volume":"73","author":"Sanak","year":"2005","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0355","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/sj.tpj.6500208","article-title":"The human dopamine D4 receptor repeat sequences modulate expression","volume":"3","author":"Schoots","year":"2003","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0360","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/(SICI)1096-8628(19991215)88:6<705::AID-AJMG22>3.0.CO;2-F","article-title":"Tandem duplication polymorphism upstream of the dopamine D4 receptor gene (DRD4)","volume":"88","author":"Seaman","year":"1999","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0365","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0140-6736(96)90440-7","article-title":"Dopamine receptors in schizophrenia","volume":"347","author":"Sedvall","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0370","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3371\/CSRP.4.1.5","article-title":"Dopamine D2 receptors as treatment targets in schizophrenia","volume":"4","author":"Seeman","year":"2010","journal-title":"Clin Schizophr Relat Psychoses"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0375","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/365441a0","article-title":"Dopamine D4 receptors elevated in schizophrenia","volume":"365","author":"Seeman","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0380","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0140-6736(93)92594-J","article-title":"Dopamine D4 receptor subtypes and response to clozapine","volume":"341","author":"Shaikh","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0385","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/ajmg.1320600611","article-title":"Analysis of clozapine response and polymorphisms of the dopamine D4 receptor gene (DRD4) in schizophrenic patients","volume":"60","author":"Shaikh","year":"1995","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0390","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0920-9964(95)95514-A","article-title":"D4 polymorphisms in schizophrenic patients treated with clozapine","volume":"15","author":"Shaikh","year":"1994","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0395","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1006\/geno.1993.1489","article-title":"Cloning of the human dopamine D5 receptor gene and identification of a highly polymorphic microsatellite for the DRD5 locus that shows tight linkage to the chromosome 4p reference marker RAF1P1","volume":"18","author":"Sherrington","year":"1993","journal-title":"Genomics"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0400","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/ajmg.b.31084","article-title":"The DRD4 receptor Exon 3 VNTR and 5\u2032 SNP variants and mRNA expression in human post-mortem brain tissue","volume":"153B","author":"Simpson","year":"2010","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0405","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1124\/mol.108.051805","article-title":"Calcium signaling by dopamine D5 receptor and D5\u2013D2 receptor hetero-oligomers occurs by a mechanism distinct from that for dopamine D1\u2013D2 receptor hetero-oligomers","volume":"75","author":"So","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0510","series-title":"Statistical package for the social sciences for Windows, rel. 17.0.0","author":"SPSS","year":"2008"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0415","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0169-328X(97)00285-4","article-title":"Elevation of D4 dopamine receptor mRNA in postmortem schizophrenic brain","volume":"53","author":"Stefanis","year":"1998","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0420","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/350614a0","article-title":"Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1","volume":"350","author":"Sunahara","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0425","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1601-183X.2010.00645.x","article-title":"Genetic factors of reaction time performance: DRD4 7-repeat allele associated with slower responses","volume":"10","author":"Szekely","year":"2011","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0430","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.psychres.2007.09.010","article-title":"Correlates of response to olanzapine in a North Indian Schizophrenia sample","volume":"161","author":"Thomas","year":"2008","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0435","doi-asserted-by":"crossref","first-page":"19350","DOI":"10.1074\/jbc.M414043200","article-title":"Folding efficiency is rate-limiting in dopamine D4 receptor biogenesis","volume":"280","author":"Van Craenenbroeck","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0440","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/350610a0","article-title":"Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine","volume":"350","author":"Van Tol","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0445","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/358149a0","article-title":"Multiple dopamine D4 receptor variants in the human population","volume":"358","author":"Van Tol","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0450","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(96)91594-9","article-title":"Monozygotic twins concordant for response to clozapine","volume":"347","author":"Vojvoda","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0455","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1086\/420854","article-title":"The genetic architecture of selection at the human dopamine receptor D4 (DRD4) gene locus","volume":"74","author":"Wang","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0460","series-title":"Dopamine in the pathophysiology and treatment of schizophrenia","article-title":"Dopamine, the prefrontal cortex, and a genetic mechanism of schizophrenia","author":"Weinberger","year":"2003"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0465","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/376572a0","article-title":"Modulation of memory fields by dopamine D1 receptors in prefrontal cortex","volume":"376","author":"Williams","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0470","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00041444-199722000-00005","article-title":"Association between schizophrenia and a microsatellite polymorphism at the dopamine D5 receptor gene","volume":"7","author":"Williams","year":"1997","journal-title":"Psychiatr Genet"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0475","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3109\/10799893.2010.513842","article-title":"The dopamine D(4) receptor, the ultimate disordered protein","volume":"30","author":"Woods","year":"2010","journal-title":"J Recept Signal Transduct Res"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0480","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0924-977X(03)00006-3","article-title":"DRD4 exon III polymorphism and response to risperidone in Israeli adolescents with schizophrenia: a pilot pharmacogenetic study","volume":"13","author":"Zalsman","year":"2003","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0485","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/genetics\/158.3.1235","article-title":"Spectrum of nonrandom associations between microsatellite loci on human chromosome 11p15","volume":"158","author":"Zapata","year":"2001","journal-title":"Genetics"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0490","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1176\/appi.ajp.2009.09040598","article-title":"D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis","volume":"167","author":"Zhang","year":"2010","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0495","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1517\/17425255.2011.532787","article-title":"Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction","volume":"7","author":"Zhang","year":"2011","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.pnpbp.2011.11.018_bb0500","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1080\/00207450590957863","article-title":"Dopamine D4 receptor gene exon III polymorphism and interindividual variation in response to clozapine","volume":"115","author":"Zhao","year":"2005","journal-title":"Int J Neurosci"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584611003502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584611003502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T08:51:32Z","timestamp":1742028692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584611003502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0278584611003502"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2011.11.018","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}